Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints

被引:4
作者
Deltuvaite-Thomas, Vaiva [1 ,2 ]
Burzykowski, Tomasz [1 ,2 ]
机构
[1] Int Drug Dev Inst, Ave Prov 30, B-1341 Louvain La Neuve, Belgium
[2] Hasselt Univ, Data Sci Inst, Diepenbeek, Belgium
关键词
clinical trials; generalized pairwise comparisons; hierarchical endpoints; net benefit; statistical power; type-I error probability; PRIORITIZED OUTCOMES; STATISTICS; BENEFIT;
D O I
10.1002/pst.2156
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The method of generalized pairwise comparisons (GPC) is a multivariate extension of the well-known non-parametric Wilcoxon-Mann-Whitney test. It allows comparing two groups of observations based on multiple hierarchically ordered endpoints, regardless of the number or type of the latter. The summary measure, "net benefit," quantifies the difference between the probabilities that a random observation from one group is doing better than an observation from the opposite group. The method takes into account the correlations between the endpoints. We have performed a simulation study for the case of two hierarchical endpoints to evaluate the impact of their correlation on the type-I error probability and power of the test based on GPC. The simulations show that the power of the GPC test for the primary endpoint is modified if the secondary endpoint is included in the hierarchical GPC analysis. The change in power depends on the correlation between the endpoints. Interestingly, a decrease in power can occur, regardless of whether there is any marginal treatment effect on the secondary endpoint. It appears that the overall power of the hierarchical GPC procedure depends, in a complex manner, on the entire variance-covariance structure of the set of outcomes. Any additional factors (such as thresholds of clinical relevance, drop out, or censoring scheme) will also affect the power and will have to be taken into account when designing a trial based on the hierarchical GPC procedure.
引用
收藏
页码:122 / 132
页数:11
相关论文
共 14 条
  • [1] Generalized pairwise comparisons of prioritized outcomes in the two-sample problem
    Buyse, Marc
    [J]. STATISTICS IN MEDICINE, 2010, 29 (30) : 3245 - 3257
  • [2] Inverse Probability of Censoring Weighted U-statistics for Right-Censored Data with an Application to Testing Hypotheses
    Datta, Somnath
    Bandyopadhyay, Dipankar
    Satten, Glen A.
    [J]. SCANDINAVIAN JOURNAL OF STATISTICS, 2010, 37 (04) : 680 - 700
  • [3] Efron B., 1967, P 5 BERK S MATH STAT
  • [4] Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial
    Garzillo, Cibele Larrosa
    Hueb, Whady
    Gersh, Bernard J.
    Lima, Eduardo Gomes
    Rezende, Paulo Cury
    Hueb, Alexandre Ciappina
    Vieira, Ricardo D'Oliveira
    Favarato, Desiderio
    Pereira, Alexandre Costa
    Soares, Paulo Rogerio
    Serrano, Carlos Vicente, Jr.
    Franchini Ramires, Jose Antonio
    Kalil Filho, Roberto
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (43) : 3370 - 3377
  • [5] One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis
    Hansen, Kirstine Norregaard
    Bendix, Kristoffcr
    Antonsen, Lisbeth
    Veien, Karsten Tange
    Maeng, Michael
    Junker, Anders
    Christiansen, Evald Hoj
    Kahlert, Johnny
    Terkelsen, Christian Juhl
    Christensen, Lotte Brix
    Fallesen, Christian Oliver
    Botker, Hans Erik
    Jensen, Lisette Okkels
    [J]. EUROINTERVENTION, 2018, 14 (08) : 926 - 934
  • [6] LATTA RB, 1977, BIOMETRIKA, V64, P633, DOI 10.1093/biomet/64.3.633
  • [7] Lee A.J., 1990, STAT TXB MONOGRAPHS, P110, DOI [10.1201/9780203734520, DOI 10.1201/9780203734520]
  • [8] Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
    Peron, J.
    Roy, P.
    Ding, K.
    Parulekar, W. R.
    Roche, L.
    Buyse, M.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (06) : 971 - 976
  • [9] An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring
    Peron, Julien
    Buyse, Marc
    Ozenne, Brice
    Roche, Laurent
    Roy, Pascal
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2018, 27 (04) : 1230 - 1239
  • [10] An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma
    Peron, Julien
    Roy, Pascal
    Conroy, Thierry
    Desseigne, Francoise
    Ychou, Marc
    Gourgou-Bourgade, Sophie
    Stanbury, Trevor
    Roche, Laurent
    Ozenne, Brice
    Buyse, Marc
    [J]. ONCOTARGET, 2016, 7 (50) : 82953 - 82960